Notice of Change to RFA-AI-18-036 Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)

Notice Number: NOT-AI-18-052

Key Dates
Release Date: August 10, 2018

Related Announcements
RFA-AI-18-036

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to update the Funding Restrictions for RFA-AI-18-036 "Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)".

Section IV. Application and Submission Information

6. Funding Restrictions

Current Language:

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

  • Awards issued under this FOA will be incrementally funded awards for project periods of up to 7 years.  Multi-year funded grants will not be awarded. 
  • Grants awarded under this FOA will be excluded from automatic carryover – all carryover requests must be approved. 
  • Grants awarded under this FOA will not be provided the authority to automatically extend the final budget period one time for up to 12 months beyond the original expiration date shown in the Notice of Award – all extensions, including the first extension, will require approval. 
  • Progress and financial reporting will be required and reviewed annually.

Revised Language:

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

  • Awards issued under this FOA will be incrementally funded awards for project periods of up to 7 years.  Multi-year funded grants will not be awarded. 
  • Grants awarded under this FOA will be excluded from automatic carryover – all carryover requests must be approved. 
  • Grants awarded under this FOA will not be provided the authority to automatically extend the final budget period one time for up to 12 months beyond the original expiration date shown in the Notice of Award – all extensions, including the first extension, will require approval. 
  • Progress and financial reporting will be required and reviewed annually.
  • All funds must be expended within the approved project period.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Jane Knisely, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3289
Email: Jane.Knisely@nih.gov